Abstract
Mannosidosis types I and II (M I/II) have been differentiated by phenotypic (Pediat.Res. 10:985,1976) and now by enzymatic characterization. M I/II variants both showed residual acidic (pH 4.4) α-mannosidase (αM) activity (1-3% of normal (N)), which was cryolablle; intriguingly, decreased neutral (pH 6.0) αM was consistently found in WBC (<25% of N) but not in fibroblasts or plasma. Thermal inactivation (55°C, pH 4.4 and pH 6.0) revealed differential αM stabilities in M I/II fibroblasts; different Km values were found only at pH 4.4. Zn++ and Co++ stimulated the residual αM in M I/II plasma and WBC. ZnSO4 (0.3mM) incubated in the media of cultured M I/II fibroblasts stimulated residual αM > 200% of untreated controls after 2d. These in vitro studies suggested that oral ZnSO4 supplementation may increase substrate catabolism in vivo. Four sibs of consanguineous parents with M II participated in a 6 mo controlled (2 treated; 2 untreated) study. The αM activities were unchanged in plasma, WBC and tears in either group. Urinary mannose-rich oligosaccharides appeared to decrease in treated patients. These results indicate 1) genetic heterogeneity of M, 2) a molecular interrelationship among the isozymes, 3) enzyme manipulation by Zn++ in vitro, and finally 4) Zn++ supplementation in M II may stimulate residual tissue αM and increase substrate catabolism.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grabowski, G., Walling, L., Ikonne, J. et al. ENZYME MANIPULATION: EVALUATION OF ORAL ZnSO4 SUP-PLEMENTATION IN MANNOSIDOSIS TYPE II. Pediatr Res 11, 456 (1977). https://doi.org/10.1203/00006450-197704000-00520
Issue Date:
DOI: https://doi.org/10.1203/00006450-197704000-00520
This article is cited by
-
Serum carnosinase deficiency: Decreased affinity of the enzyme for the substrate
Journal of Inherited Metabolic Disease (1982)